Slowly but surely, Sanofi is carving up its consumer healthcare business in an ongoing push to streamline and focus on the high-risk, high-reward pharma sector.
Now the French company is spinning off its consumer unit in India, according to a report in the Economic Times. Sanofi India will be listed as a separate entity in the country’s stock exchange. Bank of America is assisting with the demerger, ET said.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,